What is King Pharmaceuticals's general liability — year 5?

King Pharmaceuticals (KG) reported general liability — year 5 of 14% in Q4 2025.

What does general liability — year 5 mean?

Represents the total revenue or financial activity generated by the General Liability insurance segment during the fifth year of the reporting period. This metric serves as a key indicator of market penetration and demand for standard liability protection products within the company's business mix.

King Pharmaceuticals KG General Liability — Year 5

Other product segments

Commercial Auto Liability

14%—

European Hospital Liability

11.9%—

All other lines

3.6%—

International

-0.8%—

Similar metrics at other companies

CNAGeneral Liability — Year 5

14.5%+0.7pp

ORIGeneral Liability — Year 5

14.2%+0.5pp

HIGGeneral Liability — 5th Year

14.9%-0.6pp

CNAGeneral Liability — Year 6

9.8%+0.6pp

CNAGeneral Liability — Year 1

3.4%0.0pp

KMPRSpecialty Personal Automobile Insurance—Liability — Year 5

96.8%-0.6pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearFive.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's general liability — year 5.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's general liability — year 5?: King Pharmaceuticals (KG) reported general liability — year 5 of 14% in Q4 2025.
What does general liability — year 5 mean?: Represents the total revenue or financial activity generated by the General Liability insurance segment during the fifth year of the reporting period. This metric serves as a key indicator of market penetration and demand for standard liability protection products within the company's business mix.